Activation of AT receptors by Ang II, in addition to increasing vasoconstriction, leads to endothelial damage and endovascular thrombosis with activation of the coagulation cascade [82–84], which is observed in COVID-19 patients [85, 86]. This evidence concerns the gene AGT and COVID-19.